40 related articles for article (PubMed ID: 9664155)
1. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR.
Dolznig H; Grebien F; Deiner EM; Stangl K; Kolbus A; Habermann B; Kerenyi MA; Kieslinger M; Moriggl R; Beug H; Müllner EW
Oncogene; 2006 May; 25(20):2890-900. PubMed ID: 16407844
[TBL] [Abstract][Full Text] [Related]
2. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.
Han Y; Gao C; Liu Y; Zhang H; Wang S; Zhao H; Bao W; Guo X; Vinchi F; Lobo C; Shi P; Mendelson A; Luchsinger L; Zhong H; Yazdanbakhsh K; An X
Blood; 2024 Mar; 143(11):1018-1031. PubMed ID: 38127913
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Foxo3a target genes in erythropoiesis.
Bakker WJ; van Dijk TB; Parren-van Amelsvoort M; Kolbus A; Yamamoto K; Steinlein P; Verhaak RG; Mak TW; Beug H; Löwenberg B; von Lindern M
Mol Cell Biol; 2007 May; 27(10):3839-3854. PubMed ID: 17353275
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin regulation of red blood cell production: from bench to bedside and back.
Bhoopalan SV; Huang LJ; Weiss MJ
F1000Res; 2020; 9():. PubMed ID: 32983414
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin mitigated thioacetamide-induced renal injury via JAK2/STAT5 and AMPK pathway.
Elbaset MA; Mohamed BMSA; Gad SA; Afifi SM; Esatbeyoglu T; Abdelrahman SS; Fayed HM
Sci Rep; 2023 Sep; 13(1):14929. PubMed ID: 37697015
[TBL] [Abstract][Full Text] [Related]
6. SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance.
Yoshimura A; Aki D; Ito M
Proc Jpn Acad Ser B Phys Biol Sci; 2021; 97(6):277-291. PubMed ID: 34121041
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of erythropoietin on endotoxin-related organ injury in rats.
Li XJ; Zhang GX; Sun N; Sun Y; Yang LZ; Du YJ
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):680-686. PubMed ID: 24142720
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure?
Kozlov AV; Bahrami S; Calzia E; Dungel P; Gille L; Kuznetsov AV; Troppmair J
Ann Intensive Care; 2011 Sep; 1(1):41. PubMed ID: 21942988
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis.
Boucher M; Pesant S; Lei YH; Nanton N; Most P; Eckhart AD; Koch WJ; Gao E
Clin Transl Sci; 2008 May; 1(1):13-20. PubMed ID: 20443814
[TBL] [Abstract][Full Text] [Related]
10. JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells.
Breggia AC; Wojchowski DM; Himmelfarb J
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1689-95. PubMed ID: 18815218
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and renin as biological markers in critically ill patients.
Tamion F; Le Cam-Duchez V; Menard JF; Girault C; Coquerel A; Bonmarchand G
Crit Care; 2004 Oct; 8(5):R328-35. PubMed ID: 15469576
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma.
Gorio A; Gokmen N; Erbayraktar S; Yilmaz O; Madaschi L; Cichetti C; Di Giulio AM; Vardar E; Cerami A; Brines M
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9450-5. PubMed ID: 12082184
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.
Sirén AL; Fratelli M; Brines M; Goemans C; Casagrande S; Lewczuk P; Keenan S; Gleiter C; Pasquali C; Capobianco A; Mennini T; Heumann R; Cerami A; Ehrenreich H; Ghezzi P
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4044-9. PubMed ID: 11259643
[TBL] [Abstract][Full Text] [Related]
14. Physiology and function of the erythropoietin receptor.
Yoshimura A; Misawa H
Curr Opin Hematol; 1998 May; 5(3):171-6. PubMed ID: 9664155
[TBL] [Abstract][Full Text] [Related]
15. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
16. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.
Li K; Miller C; Hegde S; Wojchowski D
J Biol Chem; 2003 Oct; 278(42):40702-9. PubMed ID: 12909618
[TBL] [Abstract][Full Text] [Related]
17. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
18. STAT5 as a Key Protein of Erythropoietin Signalization.
Tóthová Z; Tomc J; Debeljak N; Solár P
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
[TBL] [Abstract][Full Text] [Related]
19. Control of erythropoiesis by erythropoietin and stem cell factor: a novel role for Bruton's tyrosine kinase.
von Lindern M; Schmidt U; Beug H
Cell Cycle; 2004 Jul; 3(7):876-9. PubMed ID: 15254422
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
